Skip to main content
Premium Trial:

Request an Annual Quote

RZPD Expands NimbleGen Array Services Offering to Include Affy IP


NEW YORK (GenomeWeb News) - The German Resource Center for Genome Research (RZPD), based in Berlin, said it has expanded an agreement with NimbleGen to cover Affymetrix’ microarray patents in Germany and Austria.
NimbleGen signed an agreement with Affymetrix in October that gave it non-exclusive, worldwide rights for the manufacture, use, and sale of nucleic acid microarrays.
Under the new agreement, RZPD will be able to offer technology covered by this IP to its customers as part of its services offering.
RZPD has been a distributor for NimbleGen in Germany and Austria for three years. It offers services such as ChIP-chp, comparative genomic hybridization, and gene expression analysis based on the NimbleGen platform.
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.